Tsereteli Z, Smith C D, Branum G D, Galloway J R, Amerson R J, Chakaraborty H, Hunter J G
Department of Surgery, Emory University Hospital, Room H122, 1364 Clifton Road N.E., Atlanta, GA 30322, USA.
Surg Endosc. 2001 Dec;15(12):1386-9. doi: 10.1007/s00464-001-8154-2.
Historically, splenectomy has been an accepted procedure in the management of immune thrombocytopenic purpura (ITP). However, it is also true that the response to splenectomy in patients with ITP seems to be unpredictable. Therefore, the purpose of this study was to identify clinical variables that might predict a favorable response to splenectomy in patients with ITP.
Data were collected retrospectively for 40 adult patients with ITP who underwent laparoscopic (LS) and open (OS) splenectomy at Emory University Hospital between 1992 and 1999. Demographics and outcomes were recorded. Age, sex, disease duration, comorbidities (ASA > 2), previous response to steroids and/or other medications, and preoperative platelet count were analyzed by univariate (t-test, Fisher's exact test) and multivariate statistical methods.
Of the 20 patients in each group, improved platelet counts were noted in 18 patients (90%) in the LS group and 20 patients (100%) in the OS group. Follow-up (16 +/- 3 months) was obtained in 19 LS patients (95%) and 16 OS patients (80%), with 84% and 87.5% sustained response rates, respectively. After univariate analysis, two variables (age and disease duration) were found to be significantly related to the outcome of splenectomy (p <lt; 0.01). However, after multiple logistic regression analysis, only disease duration (relative risk = 1.083; CI, 1.004-1.167) was an independent prognostic factor for a sustained response to splenectomy.
These results suggest that the response to splenectomy (laparoscopic and open) in patients with ITP cannot be adequately predicted on the basis of presplenectomy clinical variables. However, disease duration and patient age should be taken into consideration when selecting patients for splenectomy.
从历史上看,脾切除术一直是治疗免疫性血小板减少性紫癜(ITP)的一种公认方法。然而,ITP患者对脾切除术的反应似乎不可预测,这也是事实。因此,本研究的目的是确定可能预测ITP患者对脾切除术有良好反应的临床变量。
回顾性收集1992年至1999年在埃默里大学医院接受腹腔镜(LS)和开放性(OS)脾切除术的40例成年ITP患者的数据。记录人口统计学和手术结果。通过单变量(t检验、Fisher精确检验)和多变量统计方法分析年龄、性别、病程、合并症(ASA>2)、既往对类固醇和/或其他药物的反应以及术前血小板计数。
每组20例患者中,LS组18例(90%)患者血小板计数改善,OS组20例(100%)患者血小板计数改善。19例LS患者(95%)和16例OS患者(80%)获得随访(16±3个月),持续缓解率分别为84%和87.5%。单变量分析后,发现两个变量(年龄和病程)与脾切除术后结果显著相关(p<0.01)。然而,多因素逻辑回归分析后,只有病程(相对风险=1.083;CI,1.004 - 1.167)是脾切除术持续缓解的独立预后因素。
这些结果表明,基于脾切除术前的临床变量无法充分预测ITP患者对脾切除术(腹腔镜和开放性)的反应。然而,在选择脾切除术患者时应考虑病程和患者年龄。